_navigating-glp-1-agonists-124-dom-grand-rounds-124-17-january-2024-preview-1.jpg "Navigating GLP-1 agonists | DoM Grand Rounds | 17 January 2024 from glp 1 agonists drugs Video Screenshot Preview 1")
Gallery_navigating-glp-1-agonists-124-dom-grand-rounds-124-17-january-2024-preview-3.jpg "Navigating GLP-1 agonists | DoM Grand Rounds | 17 January 2024 from glp 1 agonists drugs Video Screenshot Preview 3")
Gallery_navigating-glp-1-agonists-124-dom-grand-rounds-124-17-january-2024-preview-hqdefault.jpg "Navigating GLP-1 agonists | DoM Grand Rounds | 17 January 2024 from glp 1 agonists drugs Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 hour 7 minutes 25 seconds
👁 View: 1.2K times
Play Audio:👁 View: 1.2K times
Description:
Stanford Department of Medicine
Stanford Department of Medicine
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_the-role-of-glp1-agonists-in-cardiovascular-care-beyond-weight-loss-a-qampa-session.webp "Joseph G. Rogers, MD presents during the Updates in Cardiovascular Disease Guidelines session at the Third Annual Global Cardiovascular Forum. nnThe Texas Heart Institute hosted this educational offering on January 20, 2024.nnMore information: www.texasheart.org/globalforum2024")
⏲ 5 min 55 sec ✓ 22-Jan-2024
_prescribing-glp-1-receptor-agonists-for-weight-loss.webp "Harvard Medical School Continuing Education")
_hims-and-hers-to-offer-weight-loss-injections.webp "Hims and Hers , to Offer Weight Loss Injections.<br/>GLP-1 medications like Ozempic and Wegovy have become increasingly popular.<br/>However, the market has faced some supply constraints recently because of that popularity.<br/>On May 20, Hims & Hers Health announced that it will be providing access to compounded GLP-1 weight loss injections, CNBC reports. .<br/>Company shares jumped over 30% <br/>following the announcement.<br/>Compounded versions of medications are created <br/>by certain manufacturers who meet FDA requirements when there are medication shortages.<br/>However, the products are not tested <br/>for safety and efficacy by the FDA.<br/>The new offering of compounded GLP-1 medications can be accessed by getting a prescription from a health care provider on the Hims & Hers site.<br/>Branded GLP-1 injections will be made available <br/>once the supply becomes more consistent.<br/>The price for compounded injections will <br/>start at $199 per month, CNBC reports. .<br/>Prior to announcing its GLP-1 offerings, <br/>Hims & Hers revealed in an earnings report...<br/>... that it anticipates its weight loss <br/>program to garner over $100 million <br/>worth of revenue by December 2025.<br/>Hims & Hers CEO Andrew Dudum said that he is \")
_glucagon-like-peptide-glp-1-and-the-treatment-of-diabetes.webp "Medicosis Perfectionalis")
_5-month-weight-loss-results-124124-compounded-semaglutide-semaglutide-weightloss-glp1.webp "Risa Beesa")
⏲ 8 minutes 20 seconds 👁 7.9K
_the-role-of-glp1-agonists-in-cardiovascular-care-beyond-weight-loss-a-qampa-session.jpg)
_prescribing-glp-1-receptor-agonists-for-weight-loss.jpg)
_hims-and-hers-to-offer-weight-loss-injections.jpg)
_glucagon-like-peptide-glp-1-and-the-treatment-of-diabetes.jpg)
_5-month-weight-loss-results-124124-compounded-semaglutide-semaglutide-weightloss-glp1.jpg)
![[+]](/images/menu.gif){kind=small}